PARP1 and lung carcinoma: Our result showed that PARP1 and HIF1A have 41 known lung cancer-specific (hypergeometric test p-value < 1.0E–20) and 30 clinically relevant (p-value = 0.04) synthetic lethal interactions between their OCRs.